Screener
Opko Health OPK Debt Issuance Proceeds
Debt Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Opko Health in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromLinesOfCredit.
The source filing: Opko Health’s 10-Q, filed July 27, 2026.
- Filed
- Jul 27, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-318090
| Line item | For the six months ended June 30, 2026 | For the six months ended June 30, 2025 |
|---|---|---|
| Cash flows from financing activities: | ||
| Share repurchase | (17,787) | (18,255) |
| Proceeds from the exercise of common stock options | (339) | (123) |
| Borrowings on lines of credit | 18,664 | 16,636 |
| Repayments of lines of credit | (18,721) | (19,387) |
| Settlement of convertible notes | — | (62,382) |
| Net cash used in financing activities | (18,183) | (83,511) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (1,053) | 3,571 |
Item 1. Financial Statements
FAQ
- What is Opko Health's debt issuance proceeds?
- Opko Health (OPK) reported debt issuance proceeds of $10.18M in Q2 2026.
- How has Opko Health's debt issuance proceeds changed year-over-year?
- Opko Health's debt issuance proceeds decreased by 7.7% year-over-year, from $11.03M to $10.18M.
- What is the long-term trend for Opko Health's debt issuance proceeds?
- Over 3 years (2021 to 2025), Opko Health's debt issuance proceeds has grown at a -73.0% compound annual growth rate (CAGR), from $1.68B to $33.03M.
- What does debt issuance proceeds mean?
- Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.
Ask your AI about Opko Health's debt issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude